These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

249 related items for PubMed ID: 21247447

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Prevalence of CYP2C19 variant alleles and pharmacodynamic variability of aspirin and clopidogrel in Native Americans.
    Oestreich JH, Best LG, Dobesh PP.
    Am Heart J; 2014 Mar; 167(3):413-8. PubMed ID: 24576527
    [Abstract] [Full Text] [Related]

  • 23. The effects of polymorphisms in CYP2C19, ATP-binding cassette transporter B1, and paraoxonase-1 on clopidogrel treatment of Uygur patients following percutaneous coronary intervention.
    Wang T, Li H, Wang F, Sun L, Yu L.
    Eur J Clin Pharmacol; 2021 Nov; 77(11):1679-1686. PubMed ID: 34164723
    [Abstract] [Full Text] [Related]

  • 24. Predicting clopidogrel response using DNA samples linked to an electronic health record.
    Delaney JT, Ramirez AH, Bowton E, Pulley JM, Basford MA, Schildcrout JS, Shi Y, Zink R, Oetjens M, Xu H, Cleator JH, Jahangir E, Ritchie MD, Masys DR, Roden DM, Crawford DC, Denny JC.
    Clin Pharmacol Ther; 2012 Feb; 91(2):257-63. PubMed ID: 22190063
    [Abstract] [Full Text] [Related]

  • 25. [Clopidogrel metabolism related gene polymorphisms in Chinese patients with acute coronary syndrome].
    Feng GX, Liang Y, Bai Y, Chen T, Liu X, Yang YM, Wang XY, Yang YJ, Zhu J.
    Zhonghua Xin Xue Guan Bing Za Zhi; 2012 Nov; 40(11):908-13. PubMed ID: 23363670
    [Abstract] [Full Text] [Related]

  • 26. Enhanced active metabolite generation and platelet inhibition with prasugrel compared to clopidogrel regardless of genotype in thienopyridine metabolic pathways.
    Braun OÖ, Angiolillo DJ, Ferreiro JL, Jakubowski JA, Winters KJ, Effron MB, Duvvuru S, Costigan TM, Sundseth S, Walker JR, Saucedo JF, Kleiman NS, Varenhorst C.
    Thromb Haemost; 2013 Dec; 110(6):1223-31. PubMed ID: 24009042
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Association Between ABCB1 Polymorphisms and Outcomes of Clopidogrel Treatment in Patients With Minor Stroke or Transient Ischemic Attack: Secondary Analysis of a Randomized Clinical Trial.
    Pan Y, Chen W, Wang Y, Li H, Johnston SC, Simon T, Zhao X, Liu L, Wang D, Meng X, Wang Y, Clopidogrel in High-Risk Patients With Acute Nondisabling Cerebrovascular Events (CHANCE) Investigators.
    JAMA Neurol; 2019 May 01; 76(5):552-560. PubMed ID: 30742211
    [Abstract] [Full Text] [Related]

  • 29. Cytochrome P450 2C19 loss-of-function polymorphism, but not CYP3A4 IVS10 + 12G/A and P2Y12 T744C polymorphisms, is associated with response variability to dual antiplatelet treatment in high-risk vascular patients.
    Giusti B, Gori AM, Marcucci R, Saracini C, Sestini I, Paniccia R, Valente S, Antoniucci D, Abbate R, Gensini GF.
    Pharmacogenet Genomics; 2007 Dec 01; 17(12):1057-64. PubMed ID: 18004210
    [Abstract] [Full Text] [Related]

  • 30. Mutational analysis clopidogrel resistance and platelet function in patients scheduled for coronary artery bypass grafting.
    Correll M, Johnson CK, Ferrari G, Brizzio M, Mak AW, Quackenbush J, Shaw RE, Zapolanski A, Grau JB.
    Genomics; 2013 Jun 01; 101(6):313-7. PubMed ID: 23462555
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Effect of genetic and coexisting polymorphisms on platelet response to clopidogrel in Chinese Han patients with acute coronary syndrome.
    Liu X, Luo Y, Lai Y, Yao Y, Li J, Wang Y, Zheng SL, Xu J, Liu X.
    J Genet; 2016 Jun 01; 95(2):231-7. PubMed ID: 27350664
    [Abstract] [Full Text] [Related]

  • 33. CYP2C19 and ABCB1 genetic polymorphisms correlate with the recurrence of ischemic cardiovascular adverse events after clopidogrel treatment.
    Hou X, Han W, Gan Q, Liu Y, Fang W.
    J Clin Lab Anal; 2018 Jun 01; 32(5):e22369. PubMed ID: 29397568
    [Abstract] [Full Text] [Related]

  • 34. [Relationship between ATP-binding cassette subfamily B member 1 and cytochrome P450 2C19 polymorphisms and the effect of clopidogrel post percutaneous coronary intervention in patients with acute coronary syndrome].
    Zhou CF, Ren YH, Song YQ, Yi J, Han BS, Xue Q, Fu ZH, Li DY.
    Zhonghua Xin Xue Guan Bing Za Zhi; 2016 Apr 24; 44(4):309-14. PubMed ID: 27112608
    [Abstract] [Full Text] [Related]

  • 35. CYP2C19*2/ABCB1-C3435T polymorphism and risk of cardiovascular events in coronary artery disease patients on clopidogrel: is clinical testing helpful?
    Singh M, Shah T, Adigopula S, Molnar J, Ahmed A, Khosla S, Arora R.
    Indian Heart J; 2012 Apr 24; 64(4):341-52. PubMed ID: 22929815
    [Abstract] [Full Text] [Related]

  • 36. Cytochrome P-450 polymorphisms and response to clopidogrel.
    Taubert D, Bouman HJ, van Werkum JW.
    N Engl J Med; 2009 May 21; 360(21):2249-50; author reply 2251. PubMed ID: 19458375
    [No Abstract] [Full Text] [Related]

  • 37. Dual therapy with clopidogrel and aspirin prevents early neurological deterioration in ischemic stroke patients carrying CYP2C19*2 reduced-function alleles.
    Lin J, Han Z, Wang C, Yi X, Chai Z, Zhou Q, Huang R.
    Eur J Clin Pharmacol; 2018 Sep 21; 74(9):1131-1140. PubMed ID: 29804161
    [Abstract] [Full Text] [Related]

  • 38. The impact of genetic polymorphisms of P2Y12, CYP3A5 and CYP2C19 on clopidogrel response variability in Iranian patients.
    Namazi S, Kojuri J, Khalili A, Azarpira N.
    Biochem Pharmacol; 2012 Apr 01; 83(7):903-8. PubMed ID: 22265638
    [Abstract] [Full Text] [Related]

  • 39. The relationship between CYP2C19 polymorphisms and ischaemic and bleeding outcomes in stable outpatients: the CHARISMA genetics study.
    Bhatt DL, Paré G, Eikelboom JW, Simonsen KL, Emison ES, Fox KA, Steg PG, Montalescot G, Bhakta N, Hacke W, Flather MD, Mak KH, Cacoub P, Creager MA, Berger PB, Steinhubl SR, Murugesan G, Mehta SR, Kottke-Marchant K, Lincoff AM, Topol EJ, CHARISMA Investigators.
    Eur Heart J; 2012 Sep 01; 33(17):2143-50. PubMed ID: 22450429
    [Abstract] [Full Text] [Related]

  • 40. CYP2C19 polymorphism and antiplatelet effects of clopidogrel in Chinese stroke patients.
    Yang J, Zhao HD, Tan J, Ding YL, Gu ZQ, Zou JJ.
    Pharmazie; 2013 Mar 01; 68(3):183-6. PubMed ID: 23556336
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.